tirzepatide blindness Is Terzepatide Causing One GLP-1 Drug May Be

VK2735 Eli Lilly and Novo Nordisk have dominated the landscape of GLP-1 therapy so far, but there are some competitors looking to challenge that dominance

10.1016/j.xkme.2022.100561 Kidney Med

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

Reducose and Blood Sugar Control Reducose, a white mulberry leaf extract, has been shown to potentially reduce post-meal glucose spikes in studies

Mitochondrial 4-HNE derived from MAO-A promotes mitoCa(2+) overload in chronic postischemic cardiac remodeling

And, glutathione supplementation with the combination of vitamin C and vitamin E can be a recipe for glowing skin